Trial intelligence / Profile preview

DTP-HB-Hib Vaccination by Jet Injector vs Needle in Infants

NCT02409095Phase 4Terminated

Sponsor
Serum Institute of India
Start
Jan 2015
Primary completion
Feb 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of diphtheria, tetanus, pertussis (whole cell), hepatitis B and haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by Serum Institute of India. Started Jan 2015; status: terminated.

02

Drugs

diphtheria, tetanus, pertussis (whole cell), hepatitis B and haemophilus influenzae type b vaccine
03

Conditions

diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)

Beyond the preview

Go deeper on NCT02409095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02409095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call